IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines.
Sobral MC, Cabizzosu L, Kang SJ, Ruark K, Najibi AJ, Lane RS, Vitner E, Ijaz H, Dellacherie MO, Dacus MT, Tringides CM, Lázaro I, Pittet MJ, Müller S, Turley SJ, Mooney DJ.
Sobral MC, et al. Among authors: ruark k.
Proc Natl Acad Sci U S A. 2024 Nov 26;121(48):e2322356121. doi: 10.1073/pnas.2322356121. Epub 2024 Nov 18.
Proc Natl Acad Sci U S A. 2024.
PMID: 39556726